DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

NCT03059485 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

BIOLOGICAL: DC/AML Fusion Vaccine
OTHER: Observation

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]
[object Object]